Breast Flashcards

(49 cards)

1
Q

Until what age is the breast classified as undergoing development?

A

25

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do fibroadenomas develop and appear?

A
  • as lobular units and dense stroma are being formed within the breast tissue
  • mobile, firm breast lumps
  • 12% of masses
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Classifications of fibroadenomas?

A
  • juvenile
  • common
  • giant (>4cm)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Investigations of fibroadenomas?

A
  • young and small <3cm on imaging - watchful waiting
  • > 4cm - core biopsy to exclude phyllodes tumour
  • very large - mastectomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How do fibroadenomas change?

A
  • 10% increase in size
  • 30% regress
  • rest remain same
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How can fibroadenomas be excised?

A
  • shelled out through circumareolar incision

- smaller lesions - mammotome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

In whom are breast cysts most common?

A

perimenopausal women caused by distended and involuted lobules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do breast cysts appear?

A
  • soft, fluctuant swellings
  • halo appearance on mammography
  • US: fluid filled
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Management of breast cysts:

A

symptomatic may be aspirated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is duct ectasia?

A
  • as women progress through menopause
  • ducts shorten and dilate
  • cheese like nipple discharge
  • slit like retraction of nipple
  • no treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Selective Oestrogen Receptor Modulators (SERM) - MOA, ADR

A
  • Tamoxifen
  • oestrogen receptor antagonist and partial agonist
  • management of oestrogen receptor positive breast cancer
  • ADR: menstrual disturbance, hot flushes, VTE, endometrial cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Aromatase inhibitors - examples, MOA, ADR

A
  • anastrozole, letrozole
  • reduce peripheral oestrogen synthesis
  • ER positive breast cancer
  • ADR: osteoporosis (DEXA scan when initiating), hot flushes, arthralgia, myalgia, insomnia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Is there increased risk of malignancy with fibroadenomas?

A

no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Is there increased risk of breast cancer with breast cysts?

A

small , especially if younger

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Management of breast cysts:

A
  • aspiration

- if blood stained or persistently refill - biopsy or excision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are sclerosing adenosis, radial scars and complex sclerosing lesions?

A
  • breast lump or pain
  • mammographic changes which mimic carcinoma
  • distortion of distal lobular unit without hyperplasia
  • disorder of involution
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Is there increased risk of malignancy with sclerosis adenosis?

A

no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Management of sclerosing adenosis:

A

biopsy, excision not mandatory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is epithelial hyperplasia?

A
  • ranges from generalised lumpiness to discrete lump
  • increased cellularity of terminal lobular unit
  • atypical features and family history of breast cancer - greatly increased risk of malignancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Management of epithelial hyperplasia:

A

no atypical features - conservative

atypical features - close monitoring or surgical resection

21
Q

What is fat necrosis?

A
  • 40% traumatic
  • physical features mimic carcinoma
  • mass may increase in size initially
22
Q

Management of fat necrosis:

A

imaging and core biopsy

23
Q

What is a duct papilloma?

A
  • present with nipple discharge
  • large papillomas - mass
  • discharge from single duct
24
Q

Is there increased risk of malignancy with duct papillomas?

25
Management of duct papillomas:
microdochectomy
26
Most common type of breast cancer:
invasive ductal carcinomas | some arise as result of ductal carcinoma in situ
27
Pathological assessment of breast cancer:
- assessment of tumour and lymph nodes | - sentinel lymph node biopsy to minimise morbidity of axillary dissection
28
Main breast cancer reconstruction type:
latissimus dorsi myocutaneous flap and sub pectoral implants
29
Indications for mastectomy:
- multifocal tumour - central tumour - large lesion in small breasts - DCIS >4cm - patient choice
30
Indications for wide local excision of breast cancer:
- solitary lesion - peripheral tumour - small lesion in large breast - DCIS <4cm - patient choice
31
What scoring system is used for breast cancer prognosis?
Nottingham Prognostic Index
32
Calculation of NPI:
tumour size x 0.2 + lymph node score + grade score
33
How does axillary lymphadenopathy determine surgical management of breast cancer?
- no palpable axillary lymphadenopathy: pre-operative axillary ultrasound before primary surgery (if positive - sentinel node biopsy to asses burden) - palpable lymphadenopathy: axillary node clearance indicated at primary surgery (may lead to arm lymphedema and functional arm impairment)
34
When is radiotherapy used in breast cancer?
- whole radiotherapy recommended after wide local excision (reduce risk of recurrence in 2/3) - mastectomy for T3-4 tumours or >=4 positive axillary nodes
35
When is hormonal therapy indicated for breast cancer?
- if positive for hormone receptors - tamoxifen pre- and peri-menopausal women - post-menopausal: aromatase inhibitors
36
How is biological therapy used in breast cancer management:
- most common: trastuzumab (Herceptin) - only in HER2 positive - not if history of heart disorders
37
How is chemotherapy used in breast cancer?
- prior to surgery to downstage primary lesion | - or after surgery e.g. axillary node disease (FEC-D used)
38
When should you refer people using suspected cancer pathway referral for an appointment within 2 weeks for breast cancer?
- >=30yo with unexplained breast lump with or without pain | - >=50yo with symptoms in one nipple of: discharge, retraction or other changes
39
When should referral for appointment in 2 weeks be considered for breast cancer?
- skin changes that suggest breast cancer | - or aged 30 and over with an unexplained lump in axilla
40
What qualifies as a non-urgent referral for breast cancer?
under 30 with unexplained breast lump with or without pain
41
Predisposing factors breast cancer:
- BRCA1 and 2 (40% lifetime risk) - 1st degree relative premenopausal breast cnacer - nulliparity (1st pregnancy >30yo) - early menarche, late menopause - combined hormone replacement therapy, COCP - past breast cancer - ionising radiation - p53 gene mutations - obesity - previous surgery for benign disease
42
NHS breast screening programme:
- 47-73 yo | - mammogram every 3 years
43
Who is offered breast cancer screening:
one first or second degree relative WITH: - age of diagnosis <40yo - bilateral breast cancer - male breast cancer - ovarian cancer - Jewish - sarcoma in relative younger than 45yo - glioma or childhood adrenal cortical carcinomas - complicated patterns of multiple cancers at young age - paternal history of breast cancer
44
Go study the anatomy of the breast
on google images
45
Most breast cancers arise from what tissue?
- duct tissue | - lobular tissue
46
All the most common types of breast cancer:
- invasive ductal carcinoma (most common) - invasive lobular carcinoma - ductal carcinoma in situ - lobular carcinoma in situ
47
Rare types of breast cancer:
- medullary - mucinous - tubular - adenoid cystic carcinoma - metaplastic - lymphoma - basal type - phyllodes or cyst-sarcoma phyllodes - papillary
48
What is paget's disease of the nipple:
- eczematoid change of nipple - underlying breast malignancy - 1-2% patients with breast cnacer - mostly with invasive carcinoma
49
What is inflammatory breast cancer?
- cancerous cells block lymph drainage | - inflamed appearance of breast